Profit Or Loss [Abstract]

Captor Therapeutics S.A. - Filing #6272138

Concept	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	124 909 869 PLN	—	—	—	—	—	—	—	—	2 014 441 PLN	—	—
Other income	—	—	3 696 PLN	—	—	—	—	—	—	—	—	20 242 PLN	—	—
Profit (loss) from operating activities	—	—	73 704 195 PLN	—	—	—	—	—	—	—	—	4 826 509 PLN	—	—
Finance income	—	—	889 653 PLN	—	—	—	—	—	—	—	—	672 993 PLN	—	—
Finance costs	—	—	939 716 PLN	—	—	—	—	—	—	—	—	12 121 PLN	—	—
Profit (loss) before tax	—	—	73 654 132 PLN	—	—	—	—	—	—	—	—	4 165 637 PLN	—	—
Tax expense (income)	—	—	9 379 416 PLN	—	—	—	—	—	—	—	—	0 PLN	—	—
Profit (loss) from continuing operations	—	—	64 274 716 PLN	—	—	—	—	—	—	—	—	4 165 637 PLN	—	—
Profit (loss) from discontinued operations	—	—	0 PLN	—	—	—	—	—	—	—	—	0 PLN	—	—
Profit (loss)	64 274 716 PLN	0 PLN	64 274 716 PLN	0 PLN	0 PLN	64 274 716 PLN	0 PLN	0 PLN	0 PLN	4 165 637 PLN	4 165 637 PLN	4 165 637 PLN	0 PLN	0 PLN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	—	64 274 716 PLN	—	—	—	—	—	—	—	—	4 165 637 PLN	—	—
Profit (loss), attributable to non-controlling interests	—	—	0 PLN	—	—	—	—	—	—	—	—	0 PLN	—	—
Earnings per share [text block]	—	—	Zysk na akcję	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations	—	—	473.00	—	—	—	—	—	—	—	—	30.00	—	—
Basic earnings (loss) per share from discontinued operations	—	—	0.00	—	—	—	—	—	—	—	—	0.00	—	—
Basic earnings (loss) per share	—	—	473.00	—	—	—	—	—	—	—	—	30.00	—	—
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations	—	—	464.00	—	—	—	—	—	—	—	—	31.00	—	—
Diluted earnings (loss) per share from discontinued operations	—	—	0.00	—	—	—	—	—	—	—	—	0.00	—	—
Diluted earnings (loss) per share	—	—	464.00	—	—	—	—	—	—	—	—	31.00	—	—